Back to search
Subarachnoid Hemorrhage of Aneurysmal Cause
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Subarachnoid Hemorrhage of Aneurysmal Cause trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Subarachnoid Hemorrhage of Aneurysmal Cause trials you may qualify forThis study will evaluate if clazosentan (on top of normal routine medical care) can reduce the risk of developing complications related to cerebral vasospasm an…
The aim of this study is to demonstrate that clazosentan, administered as a continuous intravenous infusion at 5 mg/h until Day 14 post aneurysmal subarachnoid…